Atrium Therapeutics, Inc. (RNA)
13.41
+0.11
(+0.83%)
USD |
NASDAQ |
May 14, 13:21
Atrium Therapeutics Shareholders Equity (Quarterly) : -62.71M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| KalVista Pharmaceuticals, Inc. | -2.711M |
| Intellia Therapeutics, Inc. | 620.94M |
| Recursion Pharmaceuticals, Inc. | 1.025B |
| Tango Therapeutics, Inc. | 346.18M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.948M |
| Total Liabilities (Quarterly) | 71.66M |
| Debt to Equity Ratio | -0.0586 |
| Current Ratio | 0.0391 |